Subsequent cell cycle analysis by flow cytometry indicated that silencing of PTPN3 significantly increased the G0-G1 phase cell population and decreased the S phase cell population in both cisplatin and doxorubicin resistant ovarian cancer cells. This evidence concerns the gene PTPN3 and ovarian cancer.